Saturday, November 22, 2008 - 8:30AM EST

United States

Maryland

Name of AuthorInstitutional Affiliation
Avigan MOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA.
Brinker AOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA. allen.brinker@fda.hhs.gov
Chronis AMDepartment of Psychology, University of Maryland, College Park, MD 20742, USA.
Kepley HODivision of Child Psychiatry, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA. hayden@jhmi.edu
Ostrander RDivision of Child Psychiatry, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA.
Raggi VLDepartment of Psychology, University of Maryland, College Park, MD 20742, USA. vraggi@psyc.umd.edu
Rathouz PJDepartment of Psychology, University of Maryland, College Park, MD 20742, USA.
Vitiello BChild and Adolescent Treatment and Preventive Intervention Research Branch, Division of Services and Intervention Research, National Institute of Mental Health, Room 7147, 6001 Executive Boulevard, Bethesda, MD 20892-9633, USA. bvitiell@mail.nih.gov